The latest export control regulation was put into effect2. The status of cryptography related software products remains largely the same.
The "Chui-kyo" agreed on the 2018 revision of drug reimbursement mechanism. Both trial introduction of the medical science evaluation and the annual revision represents a significant departure.
Kitamura is again featured as a leading expert in Life Science by Who's Who Legal for 2017.
The Clinical Research Law passed the Diet and will become effective within one year. Disclosure of third party funding will become mandatory.